Stockreport

Neumora (NMRA) Down on FDA Clinical Hold on Neurology Drug [Yahoo! Finance]

Neumora Therapeutics, Inc.  (NMRA) 
PDF allosteric modulator (PAM) of the M4 muscarinic receptor, for treating some types of neuropsychiatric disorders. The regulatory body placed the clinical hold after pre [Read more]